Robert Kiss
Researcher
Also affiliated: Arkansas Children's Hospital (2026); Université Libre de Bruxelles (1991–2010); Fund for Scientific Research (1996–2018); Erasmus Hospital (1991–2001); Centre Georges François Leclerc (1991); National Research Fund Luxembourg (1997)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Robert Kiss is a faculty member at the University of Arkansas for Medical Sciences with a research focus that includes targeting DNA damage response and repair mechanisms to improve the efficacy of cisplatin-based cancer treatments. His work also investigates the pathological variability associated with phenotypic differences in siblings who have ACTA1 myopathy. Kiss has published 35 papers with over 1,000 citations and holds an h-index of 17. He collaborates with researchers at his institution, including Murat Gökden, Vikki Stefans, and Fen Xia, with whom he has co-authored publications.
Metrics
- h-index: 17
- Publications: 35
- Citations: 1,010
Selected Publications
-
Pathologic Variability Associated With Phenotypic Differences in Siblings With <scp>ACTA1</scp> Myopathy (2026)
-
Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment (2021)
Collaboration Network
Top Collaborators
- Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
- Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
- Pathologic Variability Associated With Phenotypic Differences in Siblings With <scp>ACTA1</scp> Myopathy
- Pathologic Variability Associated With Phenotypic Differences in Siblings With <scp>ACTA1</scp> Myopathy
- Pathologic Variability Associated With Phenotypic Differences in Siblings With <scp>ACTA1</scp> Myopathy
- Pathologic Variability Associated With Phenotypic Differences in Siblings With <scp>ACTA1</scp> Myopathy
Similar Researchers
Based on overlapping research topics